Whales with a lot of money to spend have taken a noticeably bearish stance on Celsius Holdings. Looking at options history for Celsius Holdings CELH we detected 19 trades. If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish ...

Image source: The Motley Fool.Need a quote from one of our analysts? Email pr@fool.comMacy's ( NYSE:M ) management reported better-than-expected results on net sales, comps, and adjusted EPS in Q1 FY2025, primarily attributable to omnichannel execution, strategic discipline, and ongoing traction ...

Joby secures $250M from Toyota to boost certification and ramp up air taxi production. Archer faces short-seller heat over alleged misstatements about its eVTOL aircraft milestones. Get stock picks, daily rankings, and pro-level trading tools in one powerful platform-now 60% off for Memorial Day.

Analysing it is more important than ever. Mitigating it is a nightmare ...

AppLovin's Axon pixel adoption rose 3% in May, but churn and flat user growth kept Needham cautious with a Hold rating. Reebok, Champion, and Juicy Couture joined AppLovin's pixel, yet large-scale ad momentum remains limited, analyst says.

NEW YORK, May 28, 2025 ( GLOBE NEWSWIRE ) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed on behalf of all persons or entities who purchased the securities of Red Cat Holdings, Inc. ( Red Cat or the Company ) RCAT.

Shares of Abercrombie & Fitch ( NYSE: ANF ) are flying higher on Wednesday. The company's stock had gained 15% as of 2:36 p.m. ET. The jump came as the S&P 500 and the Nasdaq Composite were mostly flat.The clothing retailer reported its first-quarter numbers before the market opened on Wednesday, ...

Analysts see Katz's return as a catalyst for revenue and margin growth. JP Morgan upgrades Vail; BofA lifts price target on leadership shift. Get stock picks, daily rankings, and pro-level trading tools in one powerful platform-now 60% off for Memorial Day. Vail Resorts, Inc.

Ultragenyx's Q1 2025 revenue rose 28% to $139.29 million; full-year guidance was set at $640 million-$670 million. Setrusumab is projected to generate $2.4 billion in peak sales by 2037, with $1.4 billion to Ultragenyx.

Wedbush analyst Dan Ives expects Palantir and Nvidia to be the biggest beneficiaries of the AI boom. "You cannot talk AI revolution without saying Palantir," Ives says. Discover how Matt Maley trades sharp reversals-live this Wednesday, May 28 at 6 PM ET. Save your free seat now.